Articles

Results 1 to 5 of 143
Most popular |Most recent


China launches new drug reimbursement list, 148 drugs added

China - August 23 2019 On 20 August 2019, China's National Healthcare Security Administration (NHSA) and Ministry of Human Resources and Social Security (MOHRSS) jointly…

Daisy He.

AstraZeneca judgment: don’t game the system

European Union - December 12 2012 In a long-awaited judgment dated 6 December 2012, the European Court of Justice (ECJ) has confirmed that certain brand protection strategies may infringe the EU competition rules.

David Marks, John Markham.

Pharmaceutical compulsory licences in emerging markets: necessity or threat?

China, India - August 27 2013 A compulsory licence provides that the owner of a patent licenses the use of their rights in return for payment either set by law or determined…

David Pountney.

A comparison of European and Chinese regulation of biosimilar products

China, European Union - October 29 2015 Since its first biosimilar guidelines were released in 2005, the European Medicines Agency (“EMA”) has developed a detailed set of guidelines…

Jane Lin.

Novartis AG v Generics (UK) Ltd (T/A Myylan) [2012] EWCA Civ 1623 (12 December 2012)

United Kingdom - December 21 2012 Background In a High Court decision of September 2011, Mylan had obtained revocation of a basic patent and SPC owned by Novartis. Mylan intended to market…

Natalie Chopra, Simon Spink.